Nutra Pharma Corp. (NPHC)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
-0.0002 (-66.67%)
May 7, 2025, 4:00 PM EDT
Nutra Pharma Revenue
Nutra Pharma had revenue of $109.20K in the quarter ending September 30, 2022, with 466.82% growth. This brings the company's revenue in the last twelve months to $247.77K, up 185.06% year-over-year. In the year 2021, Nutra Pharma had annual revenue of $97.74K with 88.32% growth.
Revenue (ttm)
247.77K
Revenue Growth
+185.06%
P/S Ratio
2.87
Revenue / Employee
61.94K
Employees
4
Market Cap
709.97K
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2021 | 97.74K | 45.84K | 88.32% |
Dec 31, 2020 | 51.90K | -52.50K | -50.29% |
Dec 31, 2019 | 104.39K | -26.20K | -20.06% |
Dec 31, 2018 | 130.60K | 9.62K | 7.95% |
Dec 31, 2017 | 120.98K | -47.38K | -28.14% |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Dec 31, 2013 | Pro | Pro | Pro |
Dec 31, 2012 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.76B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Glass House Brands | 200.90M |
Elite Pharmaceuticals | 70.00M |
Northwest Biotherapeutics | 1.38M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |